Cardiovascular disease

Heavy news for diabetes! Johnson & Johnson Invokana approved for use in patients with type 2 diabetes and diabetic nephropathy

Johnson & Johnson (JNJ) ‘s Janssen Pharmaceuticals has announced that Health Canada has approved a new indication for the glucose-lowering drug Invokana (canagliflozin): Complementary drugs for standard care therapies for […]

Read More →

Reactive Oxygen Species

Introduction Oxygen is life sustaining, but its metabolism by organisms is not without consequences. Aerobic metabolism provides energy predominantly through mitochondrial oxidative phosphorylation. This process leads to the formation of by-products known […]

Read More →